March 20 (Reuters) - Bioextrax AB BIOEX.ST :
* SAID ON SUNDAY, ENTERS INTO TERM SHEET WITH US START-UP
REGARDING LICENSING OF CO'S TECHNOLOGIES FOR PRODUCTION OF PHA
* TERM SHEET IS IN ITSELF BINDING, BUT WILL LATER BE
REPLACED BY
LICENCE AGREEMENT
* OPTION IS INITIALLY VALID FOR ABOUT 6-8 MONTHS, PURPOSE IS
FOR
US CO TO SECURE FINANCING DURING THIS PERIOD
* FOR THIS INITIAL TIME-LIMITED OPTION, US CO PAYS USD
50,000 TO
BIOEXTRAX
* AFTER INITIAL OPTION PERIOD, US CO CAN CHOOSE TO EXTEND
OPTION
FOR MAXIMUM OF 10 MONTHS AT COST OF USD 25,000/MONTH
* IN CASE US CO CHOOSES NOT TO EXTEND OPTION, EXCLUSIVITY
EXPIRES
IMMEDIATELY
Source text for Eikon: urn:newsml:reuters.com:*:nMFN6STM1V
Further company coverage: BIOEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))